Germinal center - Wikipedia
Covid19-Sources
SARS-CoV-2 Transmission After COVID-19 Screening for Primary School Children
Eric Feigl-Ding auf Twitter: "💡New VACCINE RANKING of ability to neutralize #Omicron—Moderna appears to be the strongest against Omicron in this study, but still big drop. Pfizer next best (but we know infection efficacy is 30-34%), AstraZeneca & Sinopharm poor. J&J & Sputnik = zero.🧵https://t.co/5xmnXH2XaJ https://t.co/eZq8jbMEsQ" / Twitter
Myths of Vaccine Manufacturing
A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in Children - ScienceDirect
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study
Cognitive deficits in people who have recovered from COVID-19
Prevalence and 6‐month recovery of olfactory dysfunction: a multicentre study of 1363 COVID‐19 patients - Lechien - 2021 - Journal of Internal Medicine - Wiley Online Library
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
Epidemiology and transmission dynamics of COVID-19 in two Indian states
COVID-19 Daily Dashboard Scottland
Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA
Nasal vaccine may aid fight against new viral variants
Mortality
In the immune arsenal, antibodies offer best long-term hope against
The perils of flawed research and the ivermectin debacle
RETRACTED ARTICLE: Stay-at-home policy is a case of exception fallacy: an internet-based ecological study
Frontiers | COVID-19 Post-acute Sequelae Among Adults: 12 Month Mortality Risk | Medicine
Frontiers | Neuromechanisms of SARS-CoV-2: A Review | Frontiers in Neuroanatomy
Effects of SARS CoV-2, COVID-19, and its vaccines on male sexual health and reproduction: where do we stand?
New outlier in B.1.1.529 (Omicron-related) · Issue #367 · cov-lineages/pango-designation
„Covid-Nachwirkungen sind häufiger als wir denken“ - MRI DE
Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
Hybrid immunity
Breakthrough Infections with SARS-CoV-2 Omicron Variant Despite Booster Dose of mRNA Vaccine
The epidemiological relevance of the COVID-19-vaccinated population is increasing